Health Sciences Acquisition Corp. II (NASDAQ:HSAQ) shareholders have approved the SPAC’s planned merger with Orchestra BioMed (OBIO).

HSAQ said in a filing that its shareholders approved the deal on Jan. 24. A closing is expected later this month.

Orchestra BioMed and HSAQ announced plans to merge in July 2022, with the deal estimating the enterprise value of the combined company at $158M. Shares are expected to trade under the symbol OBIO.